Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Deeksha Bhandari2 Dec 2025 10:57 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
Ramiven: The only CDK4/6i that Delivers Proven and Deepening Protection After a 2-year Treatment Period Dr. Garima Soni28 Nov 2025 12:15 PM ISTIn the video, Dr. Carlos Barrios, director and principal investigator of the Oncology Research Center at Hospital São Lucas and president of the...
Real-World Evidence in Psoriatic Arthritis: PRO-SPIRIT Study Dr. Garima Soni25 Nov 2025 11:45 AM ISTIn the video, Dr. Nicola J. Gullick, a Consultant Rheumatologist in Coventry and one of the investigators on the PRO-SPIRIT study, provides an...
Explainer Video: Acknowledge- Assisting Patients Through Challenges in Their Diabetes Care Journey Deeksha Bhandari22 Nov 2025 12:01 PM IST Weight management is an important but challenging part of type 2 diabetes care, especially for people with overweight or obesity. Even...
Early Dose Adjustments Help Complete 2-Year Treatment Without Losing Efficacy in High-Risk Node-Positive EBC Dr. Garima Soni5 Nov 2025 12:51 PM ISTIn the video, Dr. Carlos Barrios, director and principal investigator of the oncology research center at Hospital São Lucas, and president of the...
Explainer video: Assess- Evaluating Patient Readiness for Diabetes- Management Strategies Deeksha Bhandari31 Oct 2025 12:01 PM ISTDiscussing weight with people living with type 2 diabetes can be difficult, but it is vital to improving care. Many patients with overweight or...
Importance of Identifying High-Risk Node-Positive Patients in EBC Medical Dialogues Team15 Oct 2025 11:45 AM ISTIn this video a clinical case is presented of a 54-year-old postmenopausal woman with a family history of HR+/HER2- breast cancer presented with a...
Tirzepatide proves to be more effective than semaglutide- Results of Surmount 5 Trial Deeksha Bhandari3 Oct 2025 12:09 PM ISTSURMOUNT-5 was a 72-week, Phase 3b, multicenter, randomized, open-label, comparator-controlled study that evaluated the efficacy and safety of...
Managing Nasal Congestion in Allergic Rhinitis: Whats the Mechanism of Action of Allegra D ? Deeksha Bhandari1 Sept 2025 12:45 PM ISTAllegra-D is a Schedule H prescription drug. To be sold by retail on the prescription of a Registered Medical Practitioner only.Allergic rhinitis...
Interesting cases of Wound Management Medical Dialogues Bureau8 Oct 2021 5:27 PM ISTPanel Discussion on Wound Management
Panel Discussion: Approach to Common GI disorders- Protocols& Practice Medical Dialogues Bureau8 Oct 2021 5:06 PM ISTApproach to Common GI disorders- Protocols & Practice
Wound Management - Panel discusion Meghna A Singhania8 Oct 2021 4:43 PM ISTPanel Discussion on Wound Management
